This list has 29 startups and was last updated on Oct 15, 2026. 6 of them are hiring right now. Largest teams: Ochre Bio, Healthtech 1, and Digistain. Latest round: Sava raised €32.1M (Oct 9, 2026).
What they do:
Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a €32.08 million ($36 million) Series B round to fund…
Quick facts:
HQ: London, United Kingdom
Funding:
€32.1M · Series B · Oct 2026
What they do:
Cori Clinical, a London-based startup that acts as the intelligence layer to accelerate clinical trials, has closed a €3.8 million Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures,…
Quick facts:
HQ: London, United Kingdom
Funding:
€3.8M · Seed · Oct 2026
What they do:
RNA medicines for liver diseases
Quick facts:
HQ: London, United Kingdom
50 employeesYC W20Growth stage
What they do:
Navigating patients to the right place, first time.
Quick facts:
HQ: London, United Kingdom
What they do:
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
Quick facts:
HQ: London, United Kingdom
What they do:
AI-Powered Infrastructure for Insurance & Healthcare
Quick facts:
HQ: London, United Kingdom
What they do:
Robotic human cell manufacturing
Quick facts:
HQ: London, United Kingdom
What they do:
Delivering RNA therapies.
Quick facts:
HQ: London, United Kingdom
What they do:
The next generation care enablement platform
Quick facts:
HQ: London, United Kingdom
What they do:
API for at-home health data
Quick facts:
HQ: London, United Kingdom
What they do:
AI Health Assistant for Chronic Illness
Quick facts:
HQ: London, United Kingdom
What they do:
Employee benefit for reproductive and hormone health
Quick facts:
HQ: London, United Kingdom
What they do:
Search engine for trustworthy medical information.
Quick facts:
HQ: London, United Kingdom
What they do:
Simple tests for complex diseases.
Quick facts:
HQ: London, United Kingdom
What they do:
Deliver genes to any cell with AI
Quick facts:
HQ: London, United Kingdom
What they do:
Transforming pharmacies in the UK into diagnostic centers
Quick facts:
HQ: London, United Kingdom
What they do:
AI-powered workflow automation for US healthcare providers.
Quick facts:
HQ: London, United Kingdom
What they do:
The AI scientist for always-on biodefense
Quick facts:
HQ: London, United Kingdom
What they do:
Cell-specific genetic medicines
Quick facts:
HQ: London, United Kingdom
What they do:
The unbiased AI and data layer for skin health.
Quick facts:
HQ: London, United Kingdom
2 employeesYC W21Early stageRemote
What they do:
Digital program for tinnitus
Quick facts:
HQ: London, United Kingdom
2 employeesYC W22Early stageRemote
What they do:
The frontier data platform for aligned health and biological AI
Quick facts:
HQ: London, United Kingdom
Quick facts:
HQ: London, United Kingdom
Incorporated: 2021
Funding:
$9.65M · Equity · Mar 2026
Quick facts:
HQ: London, United Kingdom
Funding:
$4.14M · Equity · Jun 2026
Quick facts:
HQ: London, United Kingdom
Incorporated: 2024
Funding:
$1.18M · Equity · Apr 2026
What they do:
Get fit fighting your way through a fantasy world.
Quick facts:
HQ: London, United Kingdom
What they do:
A self-help app for people to manage their ADHD.
Quick facts:
HQ: London, United Kingdom
What they do:
First personalized migraine clinic using genetics and telehealth.
Quick facts:
HQ: London, United Kingdom
7 employeesYC S21Early stageRemote
What they do:
Local onboarding for the $200B health tourism industry
Quick facts:
HQ: London, United Kingdom
Questions and answers
How many startups are on this list?
There are 29 startups on this list, last updated on Oct 15, 2026.
Which of them are hiring?
6 of them are hiring right now, including Healthtech 1, Curacel, and Mytos.
Which of them have the largest teams?
By team size: Ochre Bio (50 employees), Healthtech 1 (40 employees), and Digistain (40 employees).
Which of them raised money recently?
Latest rounds: Sava — €32.1M Series B (Oct 2026), Cori Clinical — €3.8M Seed (Oct 2026), and Duke Street Bio — $4.14M Equity (Jun 2026).